To provide healthcare professionals with information on the most recent developments regarding the treatment of neuropathic pain.
This activity is designed for primary care physicians, anesthesiologists, neurologists, physical medicine and rehabilitation professionals, nurse practitioners, physician assistants, clinical and consultant pharmacists, chain pharmacists, independent pharmacists, nurses in pain treatment facilities, hospital pharmacy directors, HMO and PPO P&T committee members, and hospital formulary committee chairpersons. No prerequisites required.
The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy take responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, participants should be able to:
- Describe the new neuropathic pain guidelines.
- Discuss the current knowledge of etiologies of neuropathic pain.
- Recognize the different presentations of neuropathic pain.
- Diagnose neuropathic pain.
- Implement the appropriate first-line treatment for neuropathic pain, based on the guidelines and the different pharmacokinetic and side-effect profiles of each medication, as well as their mechanisms of action.
- Use topical analgesics in appropriate patients.
- Determine strategies for implementing the guidelines in their own practice.
- Understand when nonpharmacologic treatments are indicated.
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Institute for Johns Hopkins Nursing is accredited by the American Nurses' Credentialing Center's Commission on Accreditation to provide continuing education for nurses. The University of Tennessee College of Pharmacy is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award.
The Institute for Johns Hopkins Nursing designates this educational activity for a maximum of 2 contact hours.
This program is approved for 2 hours (0.2 CEUs) and is cosponsored by the University of Tennessee College of Pharmacy, which is approved by the American Council on Pharmacy Education as a provider of continuing pharmaceutical education. A statement of CE credit will be mailed within 4 weeks of successful completion and evaluation of the program. ACPE program #064-999-04-234-H01.
Each participant should claim only those credits that he/she actually spent in the activity.
The estimated time to complete this educational activity: 2 hours.
Release date: July 15, 2004. Expiration date: July 15, 2006.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy names implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
This program is supported by an educational grant from Endo Pharmaceuticals.